Parmax Pharma Ltd. (PARMAX)
Market Open
11 Aug, 22:00
MSE MSE Primary ₹
111. 00
+2.15
+1.9752%
₹
103.82M Market Cap
- P/E Ratio
- Div Yield
151 Volume
0 Eps
₹ 108.85
Previous Close Want to track PARMAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Parmax Pharma Ltd. (PARMAX) Statistics
Valuation metrics
Market Cap 103.82M
Enterprise value 508.07M
Trailing P/E (ttm) -9.6
Forward P/E -
PEG ratio 0.13
Price/Sales (ttm) 3.3
Price/Book (mrq) -6.5
Enterprise Value/Revenue 4.19
Enterprise Value/EBITDA -14.35
Overview
Shares outstanding 3.74M
Float -
Shares short -
% Held by insiders 0.64%
% Held by institutions -
Average volume (10 days) 33K
Average volume (90 days) 13.73K
Price summary
52-Week low 22.6
52-Week high 111.27
Beta -
50-Day moving average 93.07
200-Day moving average 49.53
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.34%
Operating margin -0.38%
Operational effectiveness
Return on assets -0.15%
Return on equity 0.96%
Income Statement
Revenue (ttm) 282.04M
Revenue per share (ttm) 32.33
Quarterly revenue growth (yoy) 0.71%
Gross profit (ttm) 44.68M
EBITDA 1.8M
Net income to common (ttm) -20.94M
Diluted EPS (ttm) -11.1
Quarterly earnings growth (yoy) -0.31%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.73
Total debt (mrq) 115.1M
Total Debt/Equity (mrq) -1.87
Current ratio (mrq) 0.74%
Book value per share (mrq) -16.41
Cash Flow
Cash flow statement -20.49M
Levered free cash flow (LFCF) -20.94M
